1. Company Description
HCP, Inc. is a real estate investment trust which invests primarily in real
estate serving the healthcare industry in the U.S. The company acquires,
develops, leases, sells and manages healthcare real estate and provides
mortgage and other financing to healthcare providers. It operates through
five segments: Senior Housing, Medical Office, Life Science,
Post-Acute/Skilled Nursing and Hospital. The Senior Housing segment
includes independent living facilities, assisted living facilities and
continuing care retirement communities, which cater to different
segments of the elderly population based upon their needs. The Medical
Office segment includes pharmacies, hospital ancillary service spaceand
outpatient services such as diagnostic centers, rehabilitation clinics and
day-surgery operating rooms. These facilities are similar to commercial
office buildings as they require additional plumbing, electrical and
mechanical systems to accommodatemultiple exam rooms which may
require sinks in every room and special equipment such as x-ray
machines. The Life Science segment includes laboratory and office space
primarily for biotechnology and pharmaceutical companies, scientific
research institutions, government agencies and other organizations
involved in the life science industry. The Post-Acute/Skilled Nursing
segment offers restorative, rehabilitative and custodial nursing care. This
segment also provides services to residents beyond room and board and
2. includes occupational, physical, speech, respiratory and intravenous
therapy, wound care, oncology treatment, brain injury care and
orthopedic therapy as well as sales of pharmaceutical products and other
services. The Hospital segment includes acute care, long-term acute care
and specialty and rehabilitation hospitals. HCP was founded in March
1985 and is headquartered in Long Beach, CA.
Price history
Key Statistics
Valuation Measures
Market Cap (intraday)5: 16.67B
Enterprise Value (Sep 10, 2015)3: 28.06B
Trailing P/E (ttm, intraday): 45.72
Forward P/E (fye Dec 31, 2016)1: 11.12
PEG Ratio (5 yr expected)1: 3.34
Price/Sales (ttm): 6.99
Price/Book (mrq): 1.65
Enterprise Value/Revenue (ttm)3: 11.60
Enterprise Value/EBITDA (ttm)6: 15.58
3. Financial Highlights
Fiscal Year
Fiscal Year Ends: Dec 31
Most Recent Quarter (mrq): Jun 30, 2015
Profitability
Profit Margin (ttm): 15.24%
Operating Margin (ttm): 54.92%
Management Effectiveness
Return on Assets (ttm): 3.91%
Return on Equity (ttm): 3.54%
Income Statement
Revenue (ttm): 2.42B
Revenue Per Share (ttm): 5.26
Qtrly Revenue Growth (yoy): 13.30%
Gross Profit (ttm): 2.19B
EBITDA (ttm)6: 1.80B
Net Income Avl to Common (ttm): 366.92M
Diluted EPS (ttm): 0.79
Qtrly Earnings Growth (yoy): -24.70%
Balance Sheet
Total Cash (mrq): 115.77M
Total Cash Per Share (mrq): 0.25
Total Debt (mrq): 11.22B
Total Debt/Equity (mrq): 106.59
CurrentRatio (mrq): 16.05
Book Value Per Share (mrq): 22.13
Cash Flow Statement
Operating Cash Flow (ttm): 1.23B
Levered Free Cash Flow (ttm): 997.41
Analyst Opinion
Recommendation Summary*
Mean Recommendation (this week): 2.9
4. Mean Recommendation (lastweek): 2.9
Change: 0.0
* (Strong Buy) 1.0 - 5.0 (Sell)
Price Target Summary
Mean Target: 41.08
Median Target: 40.00
High Target: 45.00
Low Target: 38.50
No. of Brokers: 13
Options
The Dividend History
Date Dividends
2015/8/6 0.565
2015/5/7 0.565